Literature DB >> 18069925

Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat.

Hui Chen1, Bianzhi Xing, Xiuheng Liu, Bingyan Zhan, Jiangqiao Zhou, Hengcheng Zhu, Zhiyuan Chen.   

Abstract

Ischemic postconditioning is a phenomenon that intermittent interruptions of blood flow in the early phase of reperfusion can protect organ from ischemia/reperfusion (I/R) injury. In the present study, we investigated whether the protective effect of ischemic postconditioning was associated with modulation of apoptosis after renal I/R injury. Rats were subjected to 45 min of renal ischemia, both with and without treatment with ischemic postconditioning. Serum urea nitrogen and creatinine levels, phosphorylation of Akt and ERK1/2 and apoptosis were compared after renal injury. Our data showed that ischemic postconditioning attenuated the renal dysfunction and cell apoptosis induced by I/R and increased phosphorylation of Akt and ERK1/2. The results indicated that ischemic postconditioning decreased apoptosis and improved renal function. This protective effect may be related with the levels of Akt and ERK1/2 activation. These findings may have major implications in the treatment of renal transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 18069925     DOI: 10.1111/j.1432-2277.2007.00606.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  22 in total

Review 1.  New strategies to optimize kidney recovery and preservation in transplantation.

Authors:  Delphine Bon; Nicolas Chatauret; Sébastien Giraud; Raphael Thuillier; Frédéric Favreau; Thierry Hauet
Journal:  Nat Rev Nephrol       Date:  2012-05-01       Impact factor: 28.314

2.  Ischemic postconditioning inhibits apoptosis of renal cells following reperfusion: a novel in vitro model.

Authors:  Xiaodong Weng; Min Wang; Hui Chen; Zhiyuan Chen; Xiuheng Liu
Journal:  Int Urol Nephrol       Date:  2015-05-05       Impact factor: 2.370

3.  Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats.

Authors:  Anzhou Xia; Yong Li; Na Li; Zhi Xue; Jieyun Xia; Tiantian Wei; Jing Cao
Journal:  Int Urol Nephrol       Date:  2014-06-14       Impact factor: 2.370

4.  Ischemic postconditioning attenuates inflammation in rats following renal ischemia and reperfusion injury.

Authors:  Hui Chen; Lei Wang; Bian-Zhi Xing; Xiu-Heng Liu; Zhi-Yuan Chen; Xiao-Dong Weng; Tao Qiu; Lin Liu
Journal:  Exp Ther Med       Date:  2015-05-22       Impact factor: 2.447

5.  HuR inhibits apoptosis by amplifying Akt signaling through a positive feedback loop.

Authors:  Mamata Singh; Alaina R Martinez; Suman Govindaraju; Beth S Lee
Journal:  J Cell Physiol       Date:  2013-01       Impact factor: 6.384

6.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 7.  Biomarkers for ischemic preconditioning: finding the responders.

Authors:  Sebastian Koch; David Della-Morte; Kunjan R Dave; Ralph L Sacco; Miguel A Perez-Pinzon
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

8.  Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway.

Authors:  Jia Y Guo; Tong Yang; Xiang G Sun; Ni Y Zhou; Fu S Li; Dan Long; Tao Lin; Ping Y Li; Li Feng
Journal:  J Biomed Sci       Date:  2011-10-28       Impact factor: 8.410

9.  Remote ischemic conditioning enhances heart and brain antioxidant defense.

Authors:  Felipe Lobato da Silva Costa; Renan Kleber Costa Teixeira; Vitor Nagai Yamaki; André Lopes Valente; Sandro Percário; Marcus Vinicius Henriques Brito
Journal:  J Vasc Bras       Date:  2020-05-08

10.  Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment.

Authors:  Asma Mahfoudh-Boussaid; Mohamed Amine Zaouali; Thierry Hauet; Kaouther Hadj-Ayed; Abdel-Hédi Miled; Sonia Ghoul-Mazgar; Dalila Saidane-Mosbahi; Joan Rosello-Catafau; Hassen Ben Abdennebi
Journal:  J Biomed Sci       Date:  2012-08-01       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.